Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity.
Recent evidence suggests that fatty acids generated from intracellular triacylglycerol (TAG) hydrolysis may have important roles in intracellular signaling. This study was conducted to determine if fatty acids liberated from TAG hydrolysis regulate peroxisome proliferator-activated receptor alpha (PPARalpha). Primary rat hepatocyte cultures were treated with adenoviruses overexpressing adipose differentiation-related protein (ADRP) or adipose triacylglycerol lipase (ATGL) or treated with short interfering RNA (siRNA) targeted against ADRP. Subsequent effects on TAG metabolism and PPARalpha activity and target gene expression were determined. Overexpressing ADRP attenuated TAG hydrolysis, whereas siRNA-mediated knockdown of ADRP or ATGL overexpression resulted in enhanced TAG hydrolysis. Results from PPARalpha reporter activity assays demonstrated that decreasing TAG hydrolysis by ADRP overexpression resulted in a 35-60% reduction in reporter activity under basal conditions or in the presence of fatty acids. As expected, PPARalpha target genes were also decreased in response to ADRP overexpression. However, the PPARalpha ligand, WY-14643, was able to restore PPARalpha activity following ADRP overexpression. Despite its effects on PPARalpha, overexpressing ADRP did not affect PPARgamma activity. Enhancing TAG hydrolysis through ADRP knockdown or ATGL overexpression increased PPARalpha activity. These results indicate that TAG hydrolysis and the consequential release of fatty acids regulate PPARalpha activity.
Sapiro
Jessica M
JM
Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN 55108, USA.
Mashek
Mara T
MT
Greenberg
Andrew S
AS
Mashek
Douglas G
DG
D000818:Animals; D002265:Carboxylic Ester Hydrolases / Q000235:genetics / Q000378:metabolism; D002478:Cells, Cultured; D005227:Fatty Acids / Q000378:metabolism*; D015870:Gene Expression; D018014:Gene Transfer Techniques; D022781:Hepatocytes / Q000737:chemistry / Q000378:metabolism*; D006868:Hydrolysis; D008049:Lipase; D008055:Lipids / Q000032:analysis; D008297:Male; D008565:Membrane Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D047493:PPAR alpha / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D047495:PPAR gamma / Q000378:metabolism; D000070780:Perilipin-2; D020025:Peroxisome Proliferators / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D034622:RNA Interference; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D014280:Triglycerides / Q000378:metabolism*; D000217:Acyltransferases
D002265:Carboxylic Ester Hydrolases; D005227:Fatty Acids; D008049:Lipase; D008055:Lipids; D008565:Membrane Proteins; D047493:PPAR alpha; D047495:PPAR gamma; D000070780:Perilipin-2; D020025:Peroxisome Proliferators; D011743:Pyrimidines; D012333:RNA, Messenger; D014280:Triglycerides; C000602983:Plin2 protein, mouse; C000602984:Plin2 protein, rat; C006253:pirinixic acid; C494445:PNPLA2 protein, mouse; D000217:Acyltransferases